VERONESI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 7.095
EU - Europa 5.523
NA - Nord America 4.499
SA - Sud America 1.878
AF - Africa 164
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.170
Nazione #
US - Stati Uniti d'America 4.283
RU - Federazione Russa 3.559
SG - Singapore 2.351
HK - Hong Kong 1.780
CN - Cina 1.652
BR - Brasile 1.538
VN - Vietnam 624
SE - Svezia 588
FR - Francia 310
IT - Italia 310
DE - Germania 156
IE - Irlanda 148
AR - Argentina 135
BD - Bangladesh 124
FI - Finlandia 117
IN - India 116
GB - Regno Unito 114
ID - Indonesia 94
CA - Canada 80
MX - Messico 73
EC - Ecuador 64
ZA - Sudafrica 57
IQ - Iraq 44
AT - Austria 43
CO - Colombia 36
TR - Turchia 34
JP - Giappone 33
PL - Polonia 33
MY - Malesia 32
PK - Pakistan 32
ES - Italia 31
MA - Marocco 29
NL - Olanda 29
PY - Paraguay 29
VE - Venezuela 25
PH - Filippine 24
CL - Cile 18
LT - Lituania 18
UA - Ucraina 18
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 17
TH - Thailandia 17
KE - Kenya 16
TN - Tunisia 15
UZ - Uzbekistan 15
UY - Uruguay 14
EG - Egitto 12
JM - Giamaica 12
NP - Nepal 12
AZ - Azerbaigian 11
PE - Perù 11
IR - Iran 9
KZ - Kazakistan 9
DZ - Algeria 8
MD - Moldavia 8
PA - Panama 8
DO - Repubblica Dominicana 7
HN - Honduras 7
AL - Albania 6
AU - Australia 6
JO - Giordania 6
LB - Libano 6
NG - Nigeria 6
GT - Guatemala 5
NI - Nicaragua 5
OM - Oman 5
SV - El Salvador 5
BE - Belgio 4
BO - Bolivia 4
CR - Costa Rica 4
ET - Etiopia 4
RS - Serbia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BS - Bahamas 3
BY - Bielorussia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DM - Dominica 3
GR - Grecia 3
GY - Guiana 3
IL - Israele 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BH - Bahrain 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PT - Portogallo 2
RO - Romania 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
Totale 19.150
Città #
Hong Kong 1.773
Singapore 962
Dallas 943
Moscow 780
Ashburn 521
San Jose 335
Shanghai 320
Hefei 305
Lauterbourg 264
Council Bluffs 263
Lawrence 261
Princeton 261
Ho Chi Minh City 229
The Dalles 228
North Charleston 199
Dublin 147
São Paulo 134
Hanoi 130
New York 128
Beijing 118
Helsinki 89
Milan 87
Los Angeles 81
Las Vegas 58
Rio de Janeiro 52
Belo Horizonte 42
Santa Clara 38
Jakarta 36
Johannesburg 34
Guangzhou 33
Orem 33
Nuremberg 30
Warsaw 30
Boardman 29
Porto Alegre 29
Da Nang 27
Chicago 26
Tokyo 25
Montreal 24
Denver 23
Manchester 23
Mexico City 23
Brasília 22
Chennai 22
Curitiba 22
Atlanta 21
Boston 21
London 21
Munich 21
Quito 20
Salvador 20
Baghdad 19
Houston 19
Kuala Selangor 19
Lappeenranta 19
Poplar 19
Rome 19
Tianjin 19
Guayaquil 18
Hangzhou 18
Haiphong 17
Naples 17
Vienna 17
Biên Hòa 16
Brooklyn 16
Phoenix 16
Campinas 15
Guarulhos 15
Duque de Caxias 14
Hải Dương 14
Manaus 14
Mumbai 14
Nairobi 14
Thái Bình 14
Toronto 14
Ankara 13
Dhaka 13
Frankfurt am Main 13
Amsterdam 12
Bangkok 12
Bogotá 12
Charlottesville 12
Goiânia 12
New Delhi 12
Osasco 12
Seattle 12
Sorocaba 12
Stockholm 12
Tashkent 12
Baku 11
Bauru 11
Buenos Aires 11
Xi'an 11
Asunción 10
Manila 10
Phủ Lý 10
Querétaro 10
Ribeirão Preto 10
Shenzhen 10
Waynesboro 10
Totale 10.044
Nome #
Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis 826
A 10-Year Single-Center Experience on 708 Lung Metastasectomies The Evidence of the "International Registry of Lung Metastases" 184
A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes 170
Chest Drainage Therapy: What Comes out of Pandora’s Box Can Affect Patient Outcomes 147
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 140
Home-based prehabilitation: a systematic review and meta-analysis of randomised trials 135
Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids 127
Clonally expanded EOMES+ Tr1-like cells in primary and metastatic tumors are associated with disease progression 126
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP) 122
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round 120
A toolbox for functional analysis and the systematic identification of diagnostic and prognostic gene expression signatures combining meta-analysis and machine learning 119
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer 118
Surgical and Oncological Outcomes of En-Bloc Resection for Malignancies Invading the Thoracic Spine 117
Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype 117
Corrigendum to "Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos" [Lung Cancer, 131 (May) (2019) 23-30] 116
Doing More and Doing Better in Robotic Thoracic Surgery. (Lettera) 114
In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma 112
"Salvage" surgery for primary mediastinal malignancies - Is it worthwhile? 111
Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer 111
Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial 111
"Circular clamp'' excision: A new technique for lung metastasectomy 111
A Delphi Consensus report from the "Prolonged Air Leak: A Survey" study group on prevention and management of postoperative air leaks after minimally invasive anatomical resections 110
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer 110
From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma 108
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC 108
A Quantitative Method for Estimating Individual Lung Cancer Risk 108
An innovative approach to identify past exposure to asbestos integrating questionnaire information and administrative data 108
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression 107
3q26 amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: A fluorescence in situ hybridization study 106
Subpopulations of circulating cells with morphological features of malignancy are preoperatively detected and have differential prognostic significance in non-small cell lung cancer 106
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer 104
Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer 102
Different techniques in robotic lung resection 102
A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer 101
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up 99
Virtual navigation to guide personalized treatment of small-size lung cancer using minimally invasive techniques 99
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies 98
Evolution of indications for sentinel node biopsy in breast cancer 98
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 97
Adjuvant Chemotherapy in New Stage II pN0 Non-small Cell Lung Cancer: A New Issue for a Case-By-Case Decision Making Process 96
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle? 94
Early detection and early treatment of lung cancer: risks and benefits 94
Spindle Cell Nuclear in Testis Carcinoma of the Lung: A Challenging Tumor 93
Mitral Valve Systolic Anterior Motion in Robotic Thoracic Surgery as the Cause of Unexplained Hemodynamic Shock: From a Case Report to Recommendations 93
Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer 91
Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy 91
E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: Preliminary results by randomized controlled trial 89
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease 89
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases 89
High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors 88
Incidence, Management, and Outcomes of Intraoperative Catastrophes During Robotic Pulmonary Resection 85
Distinguishing multiple lung primaries from intra-pulmonary metastases and treatment implications 84
Intratumoral cellular heterogeneity: Implications for drug resistance in patients with non-small cell lung cancer 84
Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy 83
Angiogenesis inhibition in lung cancer: Emerging novel strategies 83
European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer 82
Lung cancer screening: who pays? Who receives? The European perspectives 82
Prolonged air leak after robotic lung resection: a narrative review 81
Thymoma surgery: Extreme surgical indications 80
Recommendations for implementing lung cancer screening with low-dose computed tomography in Europe 80
Venoarterial Extracorporeal Membrane Oxygenator Support in Lung Cancer Resection 79
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 79
Robotic-assisted pulmonary segmentectomies 78
Non-small-cell lung cancer 78
Robotic surgery can extend surgical indication in patients with lung cancer and impaired function 78
Robot-assisted surgery for lung cancer: State of the art and perspectives. (Review) 76
Robotic-assisted thoracoscopic thoracic duct ligation with fluorescence imaging with indocyanine green for chylothorax after thoracoabdominal aneurysm repair 75
Possible Use of Linear Echobronchoscope for Diagnosis of Peripheral Pulmonary Nodules 74
Robotic is better than VATS? Ten good reasons to prefer robotic versus manual VATS surgery in lung cancer patients 74
EXTRAPULMONARY MALIGNANCIES DIAGNOSED AT LOW-DOSE CT SCREENING FOR LUNG CANCER 73
Surgery for advanced-stage non-small cell lung cancer: Lobectomy or sub-lobar resection? 71
Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen-Detected Lung Nodules 70
Roles of computed tomography and [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography in the characterization of multiple solitary solid lung nodules 70
Biomarkers and lung cancer early detection: State of the art 70
Lung Cancer Screening: The European Perspective 69
Robotic lobectomy for non-small cell lung cancer (NSCLC): Long-term oncologic results 69
IRF4 instructs effector Treg differentiation and immune suppression in human cancer 69
Quality of life, postoperative pain, and lymph node dissection in a robotic approach compared to vats and open for early stage lung cancer 69
Four arms robotic-assisted pulmonary resection-left upper lobectomy: how to do it 68
Robotic surgery for locally advanced non-small cell lung cancer 68
Video-assisted management of malignant pleural effusion in breast carcinoma. (vol 106, pg 271, 2006) 67
Report on First International Workshop on Robotic Surgery in Thoracic Oncology 66
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly) 66
Low-dose aspirin in high-risk individuals with screen-detected subsolid lung nodules: A randomized phase II trial 65
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus 64
Results of an exploratory survey within ESTS membership in 2022 on current trend of robotic-assisted thoracic surgery and its training perspectives 64
Huge malignant localized fibrous tumor of the pleura 64
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 64
Lung Cancer Risk Prediction to Select Smokers for Screening CT-a Model Based on the Italian COSMOS Trial 63
Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors 63
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic 63
Different alternative splicing expression and plasma detection of hTERT mRNA transcripts in non-small cell lung cancer patients 62
Laparoscopic surgery for paraesophageal and large mixed hiatal hernias 62
Perioperative Blood Transfusion Practices in Oncologic Thoracic Surgery: When, Why, and How 61
Extrapulmonary Malignancies Detected at Lung Cancer Screening 61
Perioperative Outcome of Robotic Approach Versus Manual Videothoracoscopic Major Resection in Patients Affected by Early Lung Cancer: Results of a Randomized Multicentric Study (ROMAN Study) 61
Overview of the outcomes of robotic segmentectomy and lobectomy 61
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 60
Genomic characterization of asymptomatic CT-detected lung cancers 60
The attentional bias in current and former smokers 60
Totale 9.770
Categoria #
all - tutte 119.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202269 9 0 0 35 3 3 4 2 1 0 5 7
2022/20231.366 635 304 67 3 6 114 145 43 20 12 11 6
2023/2024485 5 17 27 120 40 74 18 26 21 5 12 120
2024/20254.700 579 48 31 49 59 246 380 284 1.814 654 249 307
2025/202612.720 769 1.269 1.109 2.060 768 782 889 807 3.115 736 275 141
Totale 19.405